2m 2m 2m 2m 2m 2m 2m
DRUGS MADE (DMAA)
NASDAQ
$10.61+$0.005 (+0.05%)
Price as of Jun 03, 2026 3:59 PM EDT- N/AMarket Cap
- 4.48%1-Year Change
- Shell CompaniesIndustry
DRUGS MADE (DMAA)
$10.61+$0.005 (+0.05%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 69
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$10.59
$10.61
$10.60
1-Year Range
$10.15
$10.61
$10.60
Latest Close$10.60
Change
$0.00 (0.00%)
Volume648
Shares Outstanding24.3M
P/E (TTM)40.36
Diluted EPS (TTM)$0.26
Information as of 06/02/2026
Company Profile
DRUGS MADE IN AMERICA ACQUISITION CORP
https://dmaacorp.comN/A
Market Cap
$6.0M
Net Income
Sector: Financial Services
Industry: Shell Companies
420 Lexington Avenue, New York, NY, United States, 10170
646 726 7074Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
Key Executives
- Roger Bendelac
- Saleem Elmasri
Current Ownership Distribution
- Institutions107.6M (80.17%)
- Mutual Funds17.8M (13.29%)
- Insiders8.8M (6.54%)
- Other0 (0.00%)